New combo pill aims to ease diabetic nerve pain
NCT ID NCT06715462
First seen Jan 09, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This study was designed to test whether a new drug called N0750 works better than two standard pain relievers (Cymbalta and Lyrica) for painful diabetic peripheral neuropathy. It planned to enroll adults with diabetes who have had nerve pain for at least 3 months. The main goal was to measure pain reduction over 12 weeks. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eurofarma Laboratórios S.A
Itapevi, São Paulo, 06696-000, Brazil
Conditions
Explore the condition pages connected to this study.